Molecular Epidemiology of Breast Cancer among Iranian-Azeri Population based on P۵۳ Research

  • سال انتشار: 1397
  • محل انتشار: مجله دانشگاه علوم پزشکی کرمان، دوره: 25، شماره: 3
  • کد COI اختصاصی: JR_JKMU-25-3_005
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 137
دانلود فایل این مقاله

نویسندگان

Nasser Pouladi

Assistant Professor of Cellular & Molecular Biology, Department of Biology, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, Iran

Mohammad-Ali HosseinpourFeizi

Professor of Radiobiology, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

Shideh Montasser Kouhsari

Associate Professor of Molecular Biology & Biochemistry, Department of Cellular and Molecular Biology, School of Biology, College of Sciences, University of Tehran, Tehran, Iran

Davoud Farajzadeh

Assistant Professor of Cellular & Molecular Biology, Department of Biology, Faculty of Science, Azarbaijan Shahid Madani University, Tabriz, Iran

Hourieh Khani

Ph.D. candidate of Molecular Genetics, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

Reyhaneh Ravanbakhsh Gavgani

Ph.D. candidate of Molecular Genetics, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

Narges Dastmalch

M.Sc. of Molecular Genetics, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

Yalda Arghavanian

M.Sc. of Molecular Genetics, Department of Biology, Faculty of Natural Science, University of Tabriz, Tabriz, Iran

چکیده

Background: This study was done in order to enhance our understanding about molecular and epidemiological features of breast cancer among the Azeri population with special emphasis on the detection of TP۵۳ mutations. We also analyzed the role of the P۵۳codon۷۲ polymorphism (rs۱۰۴۲۵۲۲) and its role in susceptibility to breast cancer. Methods: Tumor and control samples were collected from ۲۴۸ patients and ۱۸۹ controls. TP۵۳ mutations in exons۴-۹ and adjacent intronic regions were detected by direct sequencing in ۱۳۰ of these tumor samples. Allele-specific PCR amplification (ARMS-PCR) was used to detect polymorphisms at P۵۳codon۷۲ in ۲۴۸ patients and ۱۸۹ controls. Data were analyzed using χ۲ test or Fisher's exact and a p value of Results: We identified alterations in ۱۷.۶۹% of the exonic and intronic regions within the TP۵۳. We detected ۲۳ mutant and ۱۰۷ non-mutant samples. These mutations comprised ۲۱ single-base substitutions (۱۵-transitions and ۶-transversions), one deletion and one complex. Exon۶ was identified as a highly mutable region, with ten out of all ۲۳ (۴۳.۴۷%) observed mutations. We did not observe a significant association between polymorphism and mutation status (p > ۰.۰۵). Also, the results did not show a significant correlation between P۵۳ mutational status and clinicopathological features. Distribution differences in the P۵۳codon۷۲ polymorphism between the cases and controls were not statistically significant (p > ۰.۰۵). Conclusion: It might be concluded that P۵۳ mutational status and codon۷۲ polymorphism could not be considered as biomarker for breast cancer risk and its clinical features in the studied population. However, further investigations are needed to support these findings.

کلیدواژه ها

breast cancer, p۵۳, Codon۷۲, Mutation, Azeri population

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.